Our lab through the some pioneering work of Drs. Zhiying “Carol” Wang and ChengLin Mo and in a great partnership with the UTA Shimadzu Research Institute for Analytical Chemistry developed and validated following strict FDA clinical guidelines a new method for profiling of 158 Lipid Signaling Mediators (LMs) and currently we can precisely quantify 24 of these LMs. The importance of this method is that we can apply for cell, animal, and human studies during aging, and in pathological states. These LMs are biomolecules regulators of cell proliferation, tissue regeneration, metabolic activity, survival, inflammation.
Multi-Staged Regulation of Lipid Signaling Mediators during Myogenesis by COX-1/2 Pathways